EYLEA
- Product NDC
- 61755-005
- 11-digit product format
- 617550005
- Labeler code
- 61755
- Product ID
- 61755-005_130874ea-1e06-4ffc-b632-1dc8c73a9905
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- aflibercept
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Labeler
- Regeneron Pharmaceuticals, Inc.
- Application
- BLA125387
- Marketing category
- BLA
- Marketing start
- 2011-11-21
- Substance
- AFLIBERCEPT
- Active strength
- 40 mg/mL
- Pharmacologic classes
- Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- EYLEA
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AFLIBERCEPT | 40 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 15C2VL427D |
| Rxcui | 1232154, 1232159, 2693564, 2693567 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61755-005-01 | EYLEA | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 39 |
| 61755-005-01 | EYLEA | 0.05 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 0.05 | | 39 |
| 61755-005-02 | EYLEA | 0.05 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 0.05 | | 39 |
| 61755-005-02 | EYLEA | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 39 |
| 61755-005-54 | EYLEA | 0.05 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 0.05 | | 39 |
| 61755-005-54 | EYLEA | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 39 |
| 61755-005-55 | EYLEA | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 39 |
| 61755-005-55 | EYLEA | 0.05 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 0.05 | | 39 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| aflibercept | ACTIVE INGREDIENT | 15C2VL427D | EYLEA (AFLIBERCEPT) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.] | 12 | |
| aflibercept | ACTIVE MOIETY | 15C2VL427D | EYLEA (AFLIBERCEPT) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.] | 12 | |
| polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | EYLEA (AFLIBERCEPT) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.] | 12 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | EYLEA (AFLIBERCEPT) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.] | 12 | |
| sodium phosphate | INACTIVE INGREDIENT | SE337SVY37 | EYLEA (AFLIBERCEPT) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.] | 12 | |
| sucrose | INACTIVE INGREDIENT | C151H8M554 | EYLEA (AFLIBERCEPT) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.] | 12 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61755-005 | EYLEA (AFLIBERCEPT) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.] | 38 | Current NDC, Legacy NDC, 8 package rows | 20241024_f96cfd69-da34-41ee-90a9-610a4655cd1c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61755-005-01 | 61755000501 | 1 SYRINGE, GLASS in 1 CARTON (61755-005-01) / .05 mL in 1 SYRINGE, GLASS | 2019-12-09 | 0000-00-00 | No | No | Current |
| 61755-005-02 | 61755000502 | 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) / .05 mL in 1 VIAL, SINGLE-USE | 2011-11-21 | 0000-00-00 | No | No | Current |
| 61755-005-54 | 61755000554 | 1 SYRINGE, GLASS in 1 CARTON (61755-005-54) / .05 mL in 1 SYRINGE, GLASS | 2019-12-09 | 0000-00-00 | No | No | Current |
| 61755-005-55 | 61755000555 | 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-55) / .05 mL in 1 VIAL, SINGLE-USE | 2014-01-16 | 0000-00-00 | No | No | Current |